Dulamea A
"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania; "Fundeni" Clinical Institute, Bucharest, Romania.
J Med Life. 2015 Jan-Mar;8(1):24-7.
Multiple sclerosis is a chronic inflammatory disease of the central nervous system, characterized by an aberrant activation of the immune system and combining demyelination with neurodegeneration. Studies on experimental models of multiple sclerosis revealed immunomodulatory and immunosuppressive properties of mesenchymal stem cells. Clinical trials using mesenchymal stem cells therapy in multiple sclerosis patients showed tolerability, safety on short term, some immunomodulatory properties reducing the Th1 proinflammatory response and the inflammatory MRI parameters. The author reviews the data about experimental studies and clinical trials using mesenchymal stem cells for the treatment of multiple sclerosis.
多发性硬化症是一种中枢神经系统的慢性炎症性疾病，其特征为免疫系统异常激活，并伴有脱髓鞘和神经退行性变。对多发性硬化症实验模型的研究揭示了间充质干细胞的免疫调节和免疫抑制特性。在多发性硬化症患者中使用间充质干细胞疗法的临床试验显示出耐受性、短期安全性，以及一些免疫调节特性，可降低Th1促炎反应和炎症性MRI参数。作者综述了使用间充质干细胞治疗多发性硬化症的实验研究和临床试验数据。
